- Volume is elevated versus the 13-week average, confirming attention.
ALPAT
PAR
Week ended 07 Aug 2026
Weekly Investor Report
Plant Advanced Technologies SA · Healthcare · Biotechnology
Latest close
4.58 EUR
-6.5%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -33.3% below the Trend Line and sits at 9.1% of its 52-week range. The latest completed week returned -6.5%, after a -28.4% four-week move. The latest news-sentiment score is 59/100.
Setup score
25
out of 100
Latest Close
4.58 EUR
7 Aug 2026
1W Return
-6.5%
latest completed week
4W Return
-28.4%
short-term follow-through
12W Return
-32.1%
quarterly tape
Trend Breadth
0.0%
0 of 52 weeks active
Volume Ratio
2.8x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-6.5%
Latest completed week; four-week move -28.4%.
Indicator stack
0/34
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 38.67%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
59/100
2 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -33.3% below the Trend Line and sits at 9.1% of its 52-week range. The latest completed week returned -6.5%, after a -28.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.8x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2212-week average 0.22
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.22Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -28.4% over four weeks, -32.1% over 12 weeks, and -50.5% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.90Latest activity-pressure read.
Pressure change3.0%Four-week change in activity pressure.
Leadership-44.13Latest relative-leadership reading.
RS change-100.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment59/100
Weighted news tone is neutral across 2 relevant articles.
1 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-51.2%Distance below the 52-week high.
13-week volatility8.9%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher6 of 2617 weeks finished lower.
Best week+18.0%Week of 3 Apr.
Worst week-20.9%Week of 24 Jul.
Latest week-6.5%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains2
Flat weeks3
Modest losses12
Sharp losses5
Recent vol8.9%13-week weekly-return volatility.
Base vol6.2%52-week weekly-return volatility.
Up/down split18/31Count of positive and negative weeks in the 52-week window.
Average skew4.1% / -4.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorFR Healthcare
4-week rank74 / 76
Group average0.7%
Trend breadth26.3%
Trend26.3%active weekly trend signals
MD40.8%positive activity pressure
RS19.7%positive relative leadership
Four-week leaders
IndustryFR Biotechnology
4-week rank33 / 33
Group average4.5%
Trend breadth27.3%
Trend27.3%active weekly trend signals
MD36.4%positive activity pressure
RS21.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape25/100
Trend, activity pressure, participation, and risk combine to a 25/100 tape read.
Indicator analysis12/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.22; No reversal markers Next-Week ExpectancyNegative 38.67%Next-week expectancy is negative with a 38.67% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment59/100Weighted news tone is neutral across 2 relevant articles.
Plant Advanced Technologies Enters Court-Supervised Restructuring to Support Recovery Plan Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 4.58 EUR | -6.5% | 6.87 EUR | 9.75 EUR | -0.90 | -44.13 | 3.9K | Off |
| 31 Jul 2026 | 4.90 EUR | -7.5% | 6.97 EUR | 9.80 EUR | -0.63 | -39.61 | 7.4K | Off |
| 24 Jul 2026 | 5.30 EUR | -20.9% | 7.08 EUR | 9.85 EUR | -0.58 | -34.41 | 583 | Off |
| 17 Jul 2026 | 6.70 EUR | 4.7% | 7.18 EUR | 9.89 EUR | -0.60 | -17.67 | 195 | Off |
| 10 Jul 2026 | 6.40 EUR | 8.5% | 7.24 EUR | 9.93 EUR | -0.93 | -21.99 | 2.1K | Off |
| 3 Jul 2026 | 5.90 EUR | 7.3% | 7.31 EUR | 9.97 EUR | -0.89 | -30.04 | 120 | Off |
| 26 Jun 2026 | 5.50 EUR | 1.9% | 7.41 EUR | 10.02 EUR | -0.74 | -34.50 | 10 | Off |
| 19 Jun 2026 | 5.40 EUR | -20.0% | 7.52 EUR | 10.07 EUR | -0.48 | -36.76 | 265 | Off |
| 12 Jun 2026 | 6.75 EUR | 0.0% | 7.63 EUR | 10.12 EUR | -0.29 | -21.33 | 10 | Off |
| 5 Jun 2026 | 6.75 EUR | -2.2% | 7.69 EUR | 10.17 EUR | -0.48 | -20.85 | 732 | Off |
| 29 May 2026 | 6.90 EUR | -1.4% | 7.75 EUR | 10.21 EUR | -0.54 | -19.52 | 1.3K | Off |
| 22 May 2026 | 7.00 EUR | 3.7% | 7.80 EUR | 10.25 EUR | -0.63 | -18.47 | 650 | Off |
| 15 May 2026 | 6.75 EUR | 0.0% | 7.84 EUR | 10.29 EUR | -0.68 | -20.57 | 695 | Off |
| 8 May 2026 | 6.75 EUR | -2.2% | 7.89 EUR | 10.33 EUR | -0.45 | -22.98 | 1.4K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.